Friday, April 29, 2016

BRIEF-Teva says FDA has approved ProAir RespiClick

* Teva announces fda approval of proair respiclick

(albuterol sulfate) inhalation powder for pediatric asthma

patients ages 4 to 11

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)